Track topics on Twitter Track topics that are important to you
DUBLIN–(BUSINESS WIRE)–The “Drug Analysis: TAK-003” drug pipelines has been added to ResearchAndMarkets.com’s offering. TAK-003 (Takeda) is a needle-free, tetravalent live-attenuated vaccine currently in Phase II/III development in the US and dengue-endemic countries in Asia and Latin America, including Brazil, Colombia, … Continue reading
Cet article Global Drug Analysis: TAK-003 – Potential to Supersede Dengvaxia – ResearchAndMarkets.com est apparu en premier sur Biotech 365.NEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...